US 11851677
Composition and methods for inducing myeloid suppressive cells and use thereof
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11851677 (Composition and methods for inducing myeloid suppressive cells and use thereof) held by Fate Therapeutics, Inc. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K35/44, A61K40/10